196 related articles for article (PubMed ID: 18684964)
1. Membrane protein Crry maintains homeostasis of the complement system.
Wu X; Spitzer D; Mao D; Peng SL; Molina H; Atkinson JP
J Immunol; 2008 Aug; 181(4):2732-40. PubMed ID: 18684964
[TBL] [Abstract][Full Text] [Related]
2. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.
Barata L; Miwa T; Sato S; Kim D; Mohammed I; Song WC
J Immunol; 2013 Mar; 190(6):2886-95. PubMed ID: 23390291
[TBL] [Abstract][Full Text] [Related]
3. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
[TBL] [Abstract][Full Text] [Related]
4. The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.
Renner B; Coleman K; Goldberg R; Amura C; Holland-Neidermyer A; Pierce K; Orth HN; Molina H; Ferreira VP; Cortes C; Pangburn MK; Holers VM; Thurman JM
J Immunol; 2010 Sep; 185(5):3086-94. PubMed ID: 20675597
[TBL] [Abstract][Full Text] [Related]
5. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.
Ruseva MM; Hughes TR; Donev RM; Sivasankar B; Pickering MC; Wu X; Harris CL; Morgan BP
Mol Immunol; 2009 Feb; 46(5):803-11. PubMed ID: 18947875
[TBL] [Abstract][Full Text] [Related]
6. Properdin homeostasis requires turnover of the alternative complement pathway.
Wu X; Xu TQ; Atkinson JP
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19444-8. PubMed ID: 20974943
[TBL] [Abstract][Full Text] [Related]
7. Timing and mechanism of conceptus demise in a complement regulatory membrane protein deficient mouse.
Triebwasser MP; Wu X; Bertram P; Hourcade DE; Nelson DM; Atkinson JP
Am J Reprod Immunol; 2018 Oct; 80(4):e12997. PubMed ID: 29924462
[TBL] [Abstract][Full Text] [Related]
8. Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects.
Kang HJ; Bao L; Xu Y; Quigg RJ; Giclas PC; Holers VM
Clin Exp Immunol; 2004 May; 136(2):194-9. PubMed ID: 15086380
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.
Laskowski J; Renner B; Le Quintrec M; Panzer S; Hannan JP; Ljubanovic D; Ruseva MM; Borza DB; Antonioli AH; Pickering MC; Holers VM; Thurman JM
Kidney Int; 2016 Jul; 90(1):109-22. PubMed ID: 27165610
[TBL] [Abstract][Full Text] [Related]
10. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
11. An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.
Tchepeleva SN; Thurman JM; Ruff K; Perkins SJ; Morel L; Boackle SA
J Immunol; 2010 Aug; 185(4):2331-9. PubMed ID: 20660348
[TBL] [Abstract][Full Text] [Related]
12. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity.
Caragine TA; Imai M; Frey AB; Tomlinson S
Blood; 2002 Nov; 100(9):3304-10. PubMed ID: 12384431
[TBL] [Abstract][Full Text] [Related]
13. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
Bao L; Wang Y; Chen P; Sarav M; Haas M; Minto AW; Petkova M; Quigg RJ
Immunology; 2009 Sep; 128(1 Suppl):e895-904. PubMed ID: 19740350
[TBL] [Abstract][Full Text] [Related]
14. Absence of functional alternative complement pathway alleviates lupus cerebritis.
Alexander JJ; Jacob A; Vezina P; Sekine H; Gilkeson GS; Quigg RJ
Eur J Immunol; 2007 Jun; 37(6):1691-701. PubMed ID: 17523212
[TBL] [Abstract][Full Text] [Related]
15. Complement inhibitor Crry expression in mouse placenta is essential for maintaining normal blood pressure and fetal growth.
Banadakoppa M; Pennington K; Balakrishnan M; Yallampalli C
PLoS One; 2020; 15(8):e0236968. PubMed ID: 32745140
[TBL] [Abstract][Full Text] [Related]
16. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.
Miwa T; Zhou L; Tudoran R; Lambris JD; Madaio MP; Nangaku M; Molina H; Song WC
Mol Immunol; 2007 Jan; 44(1-3):139-46. PubMed ID: 16887189
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.
Miao J; Lesher AM; Miwa T; Sato S; Gullipalli D; Song WC
Kidney Int; 2014 Oct; 86(4):726-37. PubMed ID: 24850152
[TBL] [Abstract][Full Text] [Related]
18. A critical role for murine complement regulator crry in fetomaternal tolerance.
Xu C; Mao D; Holers VM; Palanca B; Cheng AM; Molina H
Science; 2000 Jan; 287(5452):498-501. PubMed ID: 10642554
[TBL] [Abstract][Full Text] [Related]
19. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.
Bao L; Wang Y; Chang A; Minto AW; Zhou J; Kang H; Haas M; Quigg RJ
J Am Soc Nephrol; 2007 Mar; 18(3):811-22. PubMed ID: 17229915
[TBL] [Abstract][Full Text] [Related]
20. Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry.
Miwa T; Zhou L; Kimura Y; Kim D; Bhandoola A; Song WC
Blood; 2009 Mar; 113(12):2684-94. PubMed ID: 19136662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]